Rhone Ma Holdings Bhd Market Cap ($38.06 Million)
Market Cap & Net Worth: Rhone Ma Holdings Bhd (5278)
Rhone Ma Holdings Bhd market cap. Rhone Ma Holdings Bhd (KLSE:5278) has a market capitalization of $38.06 Million (RM151.59 Million) as of November 1, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #22722 globally and #532 in its home market, demonstrating a 2.24% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rhone Ma Holdings Bhd's stock price RM0.69 by its total outstanding shares 221297664 (221.30 Million). Also see cash flow conversion of Rhone Ma Holdings Bhd for how efficiently the company converts equity into cash flow.
Rhone Ma Holdings Bhd Market Cap History (2016–2026)
Rhone Ma Holdings Bhd market cap history from 2016 to 2026. Data shows growth from $38.51 Million to $38.06 Million (1.14% CAGR). Check 5278 stock price for real-time trading data and today's change.
Rhone Ma Holdings Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rhone Ma Holdings Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Rhone Ma Holdings Bhd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.17x
Rhone Ma Holdings Bhd's market cap is 0.17 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.71x
Rhone Ma Holdings Bhd's market cap is 2.71 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $38.51 Million | $119.20 Million | $9.17 Million | 0.32x | 4.20x |
| 2017 | $39.19 Million | $137.49 Million | $13.91 Million | 0.29x | 2.82x |
| 2018 | $35.83 Million | $135.24 Million | $10.07 Million | 0.26x | 3.56x |
| 2019 | $32.66 Million | $119.06 Million | $8.64 Million | 0.27x | 3.78x |
| 2020 | $40.15 Million | $146.68 Million | $7.28 Million | 0.27x | 5.51x |
| 2021 | $37.47 Million | $169.43 Million | $11.27 Million | 0.22x | 3.33x |
| 2022 | $35.95 Million | $198.15 Million | $12.74 Million | 0.18x | 2.82x |
| 2023 | $36.98 Million | $202.93 Million | $12.08 Million | 0.18x | 3.06x |
| 2024 | $37.50 Million | $211.41 Million | $12.31 Million | 0.18x | 3.05x |
| 2025 | $38.34 Million | $223.68 Million | $14.16 Million | 0.17x | 2.71x |
Competitor Companies of 5278 by Market Capitalization
Companies near Rhone Ma Holdings Bhd in the global market cap rankings as of November 1, 2026. Also see 5278 total assets for a full breakdown of the balance sheet.
Key companies related to Rhone Ma Holdings Bhd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Rhone Ma Holdings Bhd (2016–2026)
Market capitalization of Rhone Ma Holdings Bhd from 2016 to today. Between 2016 and today, Rhone Ma Holdings Bhd's market cap moved from $38.51 Million to $ 38.06 Million, with a yearly change of 1.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM38.06 Million | -0.72% |
| 2025 | RM38.34 Million | +2.22% |
| 2024 | RM37.50 Million | +1.41% |
| 2023 | RM36.98 Million | +2.86% |
| 2022 | RM35.95 Million | -4.05% |
| 2021 | RM37.47 Million | -6.68% |
| 2020 | RM40.15 Million | +22.95% |
| 2019 | RM32.66 Million | -8.84% |
| 2018 | RM35.83 Million | -8.59% |
| 2017 | RM39.19 Million | +1.76% |
| 2016 | RM38.51 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Rhone Ma Holdings Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.06 Million USD |
| MoneyControl | $38.06 Million USD |
| MarketWatch | $38.06 Million USD |
| marketcap.company | $38.06 Million USD |
| Reuters | $38.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and … Read more